EGFR, which was highly correlated to tumor response in our study has been found overexpressed in about 40% of glioblastomas [53] with approximately 50% of tumors with EGFR amplification carrying a specific EGFR mutant (EGFRvIII) [26]. This evidence concerns the gene EGFR and neoplasm.